share this article
index in this article
Sunday by Stephen Bauer, Euro
The Göttingen laboratory supplier Sartorius is one of the top favorites of German investors. The promising business with systems for the biopharmaceutical industry offers high growth rates in sales and profits. From 2015 to 2018 alone, the share climbed from a price level of around 25 euros to around 100 euros and by the end of 2021 had multiplied further to a high of around 600 euros.
Shareholders also attributed this price increase to huge demand for laboratory equipment during the pandemic. For example, Sartorius supplies bioreactors for growing cells that are used to analyze active ingredients. The price correction was tough in the current year, the prices have almost halved. CFO Rainer Lehmann recently spoke to investors about future growth prospects and profitability dynamics. The private bank Berenberg sees a target price of 497 euros. Opportunity. building
Sartorius VJ
Industry: laboratory organization
the headquarters: Goettingen
market value: 10.9 billion euros
Editor’s note: Every week investors can vote on the main page of finanzen.net which share should be discussed. Voting runs until Wednesday. come with us! Please scroll all the way down (right)!
,
With the selected leverage product Knock-Out on Sartorius AG Vz, speculative investors can participate disproportionately in price movements. Simply select the desired lever and we will show you the appropriate open-end product at Sartorius AG Vz.
Levers 2 and 20. should be between
no data
More news about Sartorius AG Vz.
Image source: 123RF
source
